Follow-up: The evidence

Digestive Surgery

Volumn 30, Issue 2, 2013, Pages 159-168

  D'Ugo, Domenico ^a   Biondi, Alberto ^a   Tufo, Andrea ^a   Persiani, Roberto ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Gastric cancer; Postoperative follow up; Surveillance

Indexed keywords

EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; FOLLOW UP; HEALTH; HUMAN; MORTALITY; PRACTICE GUIDELINE; PROGNOSIS; QUALITY OF LIFE; REVIEW; STOMACH TUMOR; SURVIVAL RATE; TUMOR RECURRENCE;

EARLY DETECTION OF CANCER; EVIDENCE-BASED MEDICINE; FOLLOW-UP STUDIES; GUIDELINES AS TOPIC; HUMANS; NEOPLASM RECURRENCE, LOCAL; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; QUALITY OF LIFE; STOMACH NEOPLASMS; SURVIVAL RATE; WORLD HEALTH;

EID: 84880566548     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000350878     Document Type: Review

References (56)

1. Okines A, Verheij M, Allum W, Cunningham D, Cervantes A: Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 (suppl 5):v50-v54.
2. Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, Denlinger C, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Meredith K, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Washington MK, Willett C, Wood DE, Wright CD, Yang G, NCCN Gastric Cancer Panel: Gastric Cancer. J Natl Compr Canc Netw 2010; 8: 378-409.
3. Renehan AG, Egger M, Saunders MP, O'Dwyer ST: Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomized trials. BMJ 2002; 324: 813.
4. Smith TJ, Davidson NE, Schapira DV, Grunfeld E, Muss HB, Vogel VG 3rd, Somerfield MR: American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 1999; 17: 1080-1082.
5. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
6. Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S: Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer 2000; 89: 255-261.
7. Katai H, Maruyama K, Sasako M, Sano T, Okajima K, Kinoshita T, Naparkov A: Mode of recurrence after gastric cancer surgery. Dig Surg 1994; 11: 99-103.
8. Kodera Y, Ito S, Yamamura Y, Mochizuki Y, Fujiwara M, Hibi K, Ito K, Akiyama S, Nakao A: Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol 2003; 10: 898-902.
9. Whiting J, Sano T, Saka M, Fukagawa T, Katai H, Sasako M: Follow-up of gastric cancer: a review. Gastric Cancer 2006; 9: 74-81.
10. Eom BW, Yoon H, Ryu KW, Lee JH, Cho SJ, Lee JY, et al: Predictors of timing and patterns of recurrence after curative resection for gastric cancer. Dig Surg 2010; 27: 481-486.
11. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS: Recurrence following curative resection for gastric carcinoma. Br J Surg 2000; 87: 236-242.
12. Salem A, Hashem S, Mula-Hussain LY, Mohammed I, Nour A, Shelpai W, Daoud F, Morcos B, Yamin Y, Jaradat I, Khader J, Almousa A: Management strategies for locoregional recurrence in early-stage gastric cancer: retrospective analysis and comprehensive literature review. J Gastrointest Cancer 2012; 43: 77-82.
13. Tersmette AC, Offerhaus GJ, Tersmette KW, Giardiello FM, Moore GW, Tytgat GN, Vandenbroucke JP: Meta-analysis of the risk of gastric stump cancer: detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions. Cancer Res 1990; 50: 6486-6489.
14. Lundegardh G, Adami HO, Helmick C, Zack M, Meirik O: Stomach cancer after partial gastrectomy for benign ulcer disease. N Engl J Med 1988; 319: 195-200.
15. Nozaki I, Nasu J, Kubo Y, Tanada M, Nishimura R, Kurita A: Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery. World J Surg 2010; 34: 1548-1554.
16. Sakamoto Y, Ohyama S, Yamamoto J, Yamada K, Seki M, Ohta K, Kokudo N, Yamaguchi T, Muto T, Makuuchi M: Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery 2003; 133: 507-511.
17. Jensen EH, Tuttle TM: Preoperative staging and postoperative surveillance for gastric cancer. Surg Oncol Clin N Am 2007; 16: 329-342.
18. Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA, Rausch M: Modified therapy with 5-fluorouracil, doxorubicin and methotrexate in advanced gastric cancer. Cancer 1993; 72: 37-41.
19. Glimelius B, Ekstrom K, Hoffman K, Graf W, Sjodén PO, Haglund U, Svensson C, Enander LK, Linné T, Sellstrom H, Heuman R: Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 1997; 8: 163-168.
20. Pyrhoenen S, Kuitunen T, Nyandoto P, Kouri M: Randomized comparison of 5-fluorouracil, epidoxorubicin, and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995; 71: 587-591.
21. Japanese Gastric Cancer Association: Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011; 14: 113-123.
22. Eagon JC, Miedema BW, Kelly KA: Postgastrectomy syndrome. Surg Clin North Am 1992; 72: 445-465.
23. Kim HI, Hyung WJ, Song KJ, Choi SH, Kim CB, Noh SH: Oral vitamin B 12 replacement: an effective treatment for vitamin B 12 deficiency after total gastrectomy in gastric cancer patients. Ann Surg Oncol 2011; 18: 3711-3717.
24. Tovey FI, Hall ML, Ell PJ, Hobsley M: Postgastrectomy osteoporosis. Br J Surg 1991; 78: 1335-1337.
25. Tovey FI, Hobsley M: Post-gastrectomy patients need to be followed up for 20-30 years. World J Gastroenterol 2000; 6: 45-48.
26. Bae JM, Park JW, Yang HK, Kim JP: Nutritional status of gastric cancer patients after total gastrectomy. World J Surg 1998; 22: 254-260.
27. Takahashi Y, Takeuchi T, Sakamoto J, Touge T, Mai M, Ohkura H, et al: The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer 2003; 6: 142-145.
28. Ikeda Y, Mori M, Kajiyama K, Kamakura T, Maehara Y, Haraguchi Y, Sugimachi K: Indicative value of carcinoembryonic antigen (CEA) for liver recurrence following curative resection of stage II and III gastric cancer. Hepatogastroenterology 1996; 43: 1281-1287.
29. Choi SR, Jang JS, Lee JH, Roh MH, Kim MC, Lee WS, Qureshi W: Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy. Dig Dis Sci 2006; 51: 2081-2086.
30. Lai IR, Lee WJ, Huang MT, Lin HH: Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Hepatogastroenterology 2002; 49: 1157-1160.
31. Kim JH, Jang YJ, Park SS, Park SH, Mok YJ: Benefit of post-operative surveillance for recurrence after curative resection for gastric cancer. J Gastrointest Surg 2010; 14: 969-976.
32. Kim KW, Choi BI, Han JK, Kim TK, Kim AY, Lee HJ, Kim YH, Choi JI, Do KH, Kim HC, Lee MW: Postoperative anatomic and pathologic findings at CT following gastrectomy. Radiographics 2002; 22: 323-336.
33. Jadvar H, Tatlidil R, Garcia AA, Conti PS: Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography. Clin Radiol 2003; 58: 215-221.
34. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF: Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 2002; 224: 748-756.
35. Stahl A, Ott K, Weber WA, Fink U, Siewert JR, Schwaiger M: Correlation of FDG uptake in gastric carcinomas with endoscopic and histopathological findings. J Nucl Med 2001; 42: 78P-79P.
36. Park MJ, Lee WJ, Lim HK, Park KW, Choi JY, Kim BT: Detecting recurrence of gastric cancer: the value of FDG PET/CT. Abdom Imaging 2009; 34: 441-447.
37. Sun L, Su XH, Guan YS, Pan WM, Luo ZM, Wei JH, Wu H: Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results. World J Gastroenterol 2008; 14: 4627-4632.
38. Sim SH, Kim YJ, Oh DY, Lee SH, Kim DW, Kang WJ, Im SA, Kim TY, Kim WH, Heo DS, Bang YJ: The role of PET/CT in detection of gastric cancer recurrence. BMC Cancer 2009; 9: 73.
39. Ozkan E, Araz M, Soydal C, Kucuk ON: The role of 18F-FDG-PET/CT in the preoperative staging and post-therapy follow-up of gastric cancer: comparison with spiral CT. World J Surg Oncol 2011; 9: 75.
40. Meyers MA, McSweeney J: Secondary neoplasms of the bowel. Radiology 1972; 105: 1-11.
41. Inoue K, Nakane Y, Michiura T, Yamaki S, Yui R, Sakuramoto K, Iwai A, Tokuhara K, Araki Y, Kim S, Nakai K, Sato M, Yamamichi K, Kwon AH: Feasibility and accuracy of second look laparoscopy after gastrectomy for gastric cancer. Surg Endosc 2009; 23: 2307-2313.
42. Lee SY, Lee JH, Hwang NC, Kim YH, Rhee PL, Kim JJ, Paik SW, Rhee JC, Sohn TS, Kim S: The role of follow-up endoscopy after total gastrectomy for gastric cancer. Eur J Surg Oncol 2005; 31: 265-269.
43. Fujita T, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kinoshita T: Relationship between the histological type of initial lesions and the risk for the development of remnant gastric cancers after gastrectomy for synchronous multiple gastric cancers. World J Surg 2010; 34: 296-302.
44. Ohashi M, Katai H, Fukagawa T, Gotoda T, Sano T, Sasako M: Cancer of the gastric stump following distal gastrectomy for cancer. Br J Surg 2007; 94: 92-95.
45. Greene FL: Management of gastric remnant carcinoma based on the results of a 15-year endoscopic screening program. Ann Surg 1996; 223: 701-708.
46. Kikuchi S, Sato M, Katada N, Sakuramoto S, Shimao H, Kakita A, Ohida M, Saigenji K: Efficacy of endoscopic surveillance of the upper gastrointestinal tract following distal gastrectomy for early gastric cancer. Hepatogastroenterology 2003; 50: 1704-1707.
47. Kato M, Nishida T, Yamamoto K, Hayashi S, Kitamura S, Yabuta T, Yoshio T, Nakamura T, Komori M, Kawai N, Nishihara A, Nakanishi F, Nakahara M, Ogiyama H, Kinoshita K, Yamada T, Iijima H, Tsujii M, Takehara T: Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group. Gut 2012, E-pub ahead of print.
48. Böhner H, Zimmer T, Hopfenmüller W, Berger G, Buhr HJ: Detection and prognosis of recurrent gastric cancer -is routine followup after gastrectomy worthwhile' Hepatogastroenterology 2000; 47: 1489-1494.
49. Tan IT, So BY: Value of intensive follow-up of patients after curative surgery for gastric carcinoma: J Surg Oncol 2007; 96: 503-506.
50. Bennett JJ, Gonen M, D'Angelica M, Jaques DP, Brennan MF, Coit DG: Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer' J Am Coll Surg 2005; 201: 503-510.
51. Bilici A, Salman T, Oven Ustaalioglu BB, Unek T, Seker M, Aliustaoglu M, Gezen C, Unek T, Yavuzer D, Unlu M, Gumus M, Yilmaz U: The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy. J Surg Res 2013; 180:e1-e9.
52. Cardoso R, Coburn NG, Seevaratnam R, Mahar A, Helyer L, Law C, Singh S: A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review. Gastric Cancer 2012; 15(suppl 1):164-167.
53. Allum WH, Blazeby JM, Griffin SM, Cunningham D, Jankowski JA, Wong R, Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, the British Society of Gastroenterology and the British Association of Surgical Oncology: Guidelines for the management of oesophageal and gastric cancer. Gut 2011; 60: 1449-1472.
54. Marrelli D, Morgagni P, de Manzoni G, Coniglio A, Marchet A, Saragoni L, Tiberio G, Roviello F, Italian Research Group for Gastric Cancer (IRGGC): Prediction of recurrence after radical surgery for gastric cancer. A scoring system obtained from a prospective multicenter study. Ann Surg 2005; 241: 247-255.
55. Sibbald B, Roland M: Understanding controlled trials: why are randomised controlled trials important' BMJ 1998; 316: 201.
56. Jones J, Hunter D: Consensus methods for medical and health services research. BMJ 1995; 311: 376-378.